Biotechnology Innovation Organization (BIO) joined the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and five other industry groups in a commitment to action to ensure equitable distribution of COVID-19 vaccines.
Global vaccine manufacturers increased production “in just a few months from zero to 2.2 billion COVID-19 vaccine doses by the end of May,” says the statement, with 11 billion doses projected by year’s end—but more action is needed to ensure equitable distribution. So, we commit to these five steps…